The Journal of Practical Medicine >
The mechanism of cyclin D1 ameliorates renal ischemia⁃reperfusion⁃induced acute kidney injury by promotingglycolysis
Received date: 2024-07-25
Online published: 2024-11-19
Objective To investigate the impact of CCND1 on renal ischemia?reperfusion?induced acute kidney injury through the promotion of glycolysis and elucidate its underlying molecular mechanism， thereby offering a novel therapeutic target for acute kidney injury. Methods We selected 8?week?old male C57BL/6 mice to establish a model of renal ischemia?reperfusion injury (IRI). To investigate the role of CCND1 in acute kidney injury (AKI)， we employed a CCND1 overexpression plasmid and a CCND1 interference plasmid for both in vivo and in vitro experiments. Kidney function was evaluated using creatinine and urea nitrogen test kits， while glycolysis and indicators of renal tubule epithelial cell damage were assessed through quantitative real?time PCR， Western blotting， immunohistochemistry， and immunofluorescence techniques. Results In the model of renal ischemia?reperfusion?induced acute renal injury， down?regulation of CCND1 expression in renal tubular epithelial cells resulted in cellular and tissue damage. However， when an overexpression plasmid for CCND1 was administered in vivo， it significantly improved kidney function and reduced kidney injury in IRI mice. The overexpression of CCND1 promoted glycolysis， pyruvate production， and increased energy production. We further confirmed the role of CCND1 in vitro where its overexpression promoted glycolysis， enhanced energy production， and alleviated AKI. Conversely， knockdown of CCND1 inhibited glycolysis leading to severe impairment in cell energy production and exacerbation of injury. Conclusions In summary， down?regulation of CCND1 expression in renal tubular epithelial cells is observed in acute kidney injury， while overexpression of CCND1 can ameliorate acute kidney injury induced by renal ischemia?reperfusion. This mechanism may be attributed to the promotion of glycolysis and timely restoration of energy supply to cells and tissues facilitated by CCND1 overexpression.
Yuliang HUANG , Ying TANG , Wenjuan YU , Junzhe. CHEN . The mechanism of cyclin D1 ameliorates renal ischemia⁃reperfusion⁃induced acute kidney injury by promotingglycolysis[J]. The Journal of Practical Medicine, 2024 , 40(21) : 3013 -3022 . DOI: 10.3969/j.issn.1006-5725.2024.21.009
| 1 | BASILE D P， ANDERSON M D， SUTTON T A. Pathophysiology of acute kidney injury ［J］. Compr Physiol， 2012， 2（2）：1303-1353. |
| 2 | VENKATACHALAM M A， WEINBERG J M， KRIZ W， et al. Failed Tubule Recovery， AKI-CKD Transition， and Kidney Disease Progression ［J］. J Am Soc Nephrol， 2015， 26（8）： 1765-1776. doi:10.1681/asn.2015010006 |
| 3 | BOUCHARD J， ACHARYA A， CERDA J， et al. A Prospective International Multicenter Study of AKI in the Intensive Care Unit ［J］. Clin J Am Soc Nephrol， 2015， 10（8）： 1324-1331. doi:10.2215/cjn.04360514 |
| 4 | HOSTE E A， BAGSHAW S M， BELLOMO R， et al. Epidemiology of acute kidney injury in critically ill patients： the multinational AKI-EPI study ［J］. Intensive Care Med， 2015， 41（8）： 1411-1423. doi:10.1007/s00134-015-3934-7 |
| 5 | RONCO C， BELLOMO R， KELLUM J A. Acute kidney injury ［J］. Lancet， 2019， 394（10212）： 1949-1964. doi:10.1016/s0140-6736(19)32563-2 |
| 6 | KELLUM J A. Acute kidney injury ［J］. Nat Rev Dis Primers， 2021， 7（1）： 52. doi:10.1038/s41572-021-00291-0 |
| 7 | HOTCHKISS R S. Cell death ［J］. N Engl J Med， 2009， 361（16）： 1570-1583. doi:10.1056/nejmra0901217 |
| 8 | SHI H， GAO Y， DONG Z， et al. GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury ［J］. Circ Res， 2021， 129（3）： 383-396. doi:10.1161/circresaha.120.318629 |
| 9 | VAN DER RIJT S， LEEMANS J C， FLORQUIN S， et al. Immunometabolic rewiring of tubular epithelial cells in kidney disease ［J］. Nat Rev Nephrol， 2022， 18（9）： 588-603. doi:10.1038/s41581-022-00592-x |
| 10 | CHAWLA L S， EGGERS P W， STAR R A， et al. Acute kidney injury and chronic kidney disease as interconnected syndromes ［J］. N Engl J Med， 2014， 371（1）： 58-66. doi:10.1056/nejmra1214243 |
| 11 | KWIATKOWSKA E， KWIATKOWSKI S， DZIEDZIEJKO V， et al. Renal Microcirculation Injury as the Main Cause of Ischemic Acute Kidney Injury Development ［J］. Biology （Basel）， 2023， 12（2）： 327. doi:10.3390/biology12020327 |
| 12 | LEVEY A S. Defining AKD： The Spectrum of AKI， AKD， and CKD ［J］. Nephron， 2022， 146（3）： 302-305. doi:10.1159/000516647 |
| 13 | WANG Z， YING Z， BOSY-WESTPHAL A， et al. Specific metabolic rates of major organs and tissues across adulthood： evaluation by mechanistic model of resting energy expenditure ［J］. Am J Clin Nutr， 2010， 92（6）： 1369-1377. doi:10.3945/ajcn.2010.29885 |
| 14 | SABBAHY M EL， VAIDYA V S. Ischemic kidney injury and mechanisms of tissue repair ［J］. Wiley Interdiscip Rev Syst Biol Med， 2011， 3（5）： 606-618. doi:10.1002/wsbm.133 |
| 15 | FORBES J M. Mitochondria-Power Players in Kidney Function？ ［J］. Trends Endocrinol Metab， 2016， 27（7）： 441-442. doi:10.1016/j.tem.2016.05.002 |
| 16 | ISAKA Y， KIMURA T， TAKABATAKE Y. The protective role of autophagy against aging and acute ischemic injury in kidney proximal tubular cells ［J］. Autophagy， 2011， 7（9）： 1085-1087. doi:10.4161/auto.7.9.16465 |
| 17 | MALEK M， NEMATBAKHSH M. Renal ischemia/reperfusion injury； from pathophysiology to treatment ［J］. J Renal Inj Prev， 2015， 4（2）： 20-27. |
| 18 | MULUKUTLA B C， YONGKY A， LE T， et al. Regulation of Glucose Metabolism-A Perspective From Cell Bioprocessing ［J］. Trends Biotechnol， 2016， 34（8）： 638-651. doi:10.1016/j.tibtech.2016.04.012 |
| 19 | WEN L， LI Y， LI S， et al. Glucose Metabolism in Acute Kidney Injury and Kidney Repair ［J］. Front Med （Lausanne）， 2021， 8： 744122. doi:10.3389/fmed.2021.744122 |
| 20 | CANTELMO A R， CONRADI L C， BRAJIC A， et al. Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization， Impairs Metastasis， and Improves Chemotherapy ［J］. Cancer Cell， 2016， 30（6）： 968-985. doi:10.1016/j.ccell.2016.10.006 |
| 21 | DICKMAN K G， MANDEL L J. Differential effects of respiratory inhibitors on glycolysis in proximal tubules ［J］. Am J Physiol， 1990， 258（6 Pt 2）： F1608-1615. doi:10.1152/ajprenal.1990.258.6.f1608 |
| 22 | SHERR C J， ROBERTS J M. Living with or without cyclins and cyclin-dependent kinases ［J］. Genes Dev， 2004， 18（22）： 2699-2711. doi:10.1101/gad.1256504 |
| 23 | ALAO J P， GAMBLE S C， STAVROPOULOU A V， et al. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines ［J］. Mol Cancer， 2006， 5：7. doi:10.1186/1476-4598-5-7 |
| 24 | TCHAKARSKA G， SOLA B. The double dealing of cyclin D1 ［J］. Cell Cycle， 2020， 19（2）：163-178. doi:10.1080/15384101.2019.1706903 |
| 25 | PESTELL R G. New roles of cyclin D1 ［J］. Am J Pathol， 2013， 183（1）： 3-9. doi:10.1016/j.ajpath.2013.03.001 |
| 26 | LIU G X， LI YQ， HUANG X R， et al. Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension ［J］. Clin Sci （Lond）， 2014， 127（3）： 195-208. doi:10.1042/cs20130706 |
| 27 | FU S， TANG Y， HUANG X R， et al. Smad7 protects against acute kidney injury by rescuing tubular epithelial cells from the G1 cell cycle arrest ［J］. Clin Sci （Lond）， 2017， 131（15）： 1955-1969. doi:10.1042/cs20170127 |
| 28 | LIS P， DYL?G M， NIED?WIECKA K， et al. The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer： Targets for Effective Therapy with 3-Bromopyruvate ［J］. Molecules， 2016， 21（12）： 1730. doi:10.3390/molecules21121730 |
| 29 | BELLOMO R， KELLUM J A， RONCO C. Acute kidney injury ［J］. Lancet， 2012， 380（9843）： 756-766. doi:10.1016/s0140-6736(11)61454-2 |
| 30 | ALI T， KHAN I， SIMPSON W， et al. Incidence and outcomes in acute kidney injury： a comprehensive population-based study ［J］. J Am Soc Nephrol， 2007， 18（4）： 1292-1298. doi:10.1681/asn.2006070756 |
| 31 | PAGLIARINI D J， CALVO S E， CHANG B， et al. A mitochondrial protein compendium elucidates complex I disease biology ［J］. Cell， 2008， 134（1）： 112-123. doi:10.1016/j.cell.2008.06.016 |
| 32 | O'CONNOR P M. Renal oxygen delivery： matching delivery to metabolic demand ［J］. Clin Exp Pharmacol Physiol， 2006， 33（10）： 961-967. doi:10.1111/j.1440-1681.2006.04475.x |
| 33 | SUN J， ZHANG J， TIAN J， et al. Mitochondria in Sepsis-Induced AKI ［J］. J Am Soc Nephrol， 2019， 30（7）： 1151-1161. doi:10.1681/asn.2018111126 |
| 34 | JIANG M， BAI M， LEI J， et al. Mitochondrial dysfunction and the AKI-to-CKD transition ［J］. Am J Physiol Renal Physiol， 2020， 319（6）： F1105-F1116. doi:10.1152/ajprenal.00285.2020 |
| 35 | RYOO S M， LEE J， LEE Y S， et al. Lactate Level Versus Lactate Clearance for Predicting Mortality in Patients With Septic Shock Defined by Sepsis-3 ［J］. Crit Care Med， 2018， 46（6）： e489-e495. doi:10.1097/ccm.0000000000003030 |
| 36 | ZAGER R A， JOHNSON A C， BECKER K. Renal cortical pyruvate depletion during AKI ［J］. J Am Soc Nephrol， 2014， 25（5）： 998-1012. doi:10.1681/asn.2013070791 |
| 37 | ZAGER R A， JOHNSON A C， NAITO M， et al. Maleate nephrotoxicity： mechanisms of injury and correlates with ischemic/hypoxic tubular cell death ［J］. Am J Physiol Renal Physiol， 2008， 294（1）： F187-197. doi:10.1152/ajprenal.00434.2007 |
/
| 〈 |
|
〉 |